“Shakti M is known to me from last few years with respect to BioAsia. I have found Shakti very responsive, thorough professional & easy to interact with. He is methodical and keeps a very practical approach. He maintains a very strong customer relationship. He has a very cool head on his shoulders. I wish him all the success.”
About
As the CEO of Telangana Lifesciences, I lead initiatives that drive innovation and growth…
Activity
-
Very happy to inaugurate the expansion of Medtronic’s GEIC in Hyderabad last week. The US based medical devices giant, Medtronic’s growing…
Very happy to inaugurate the expansion of Medtronic’s GEIC in Hyderabad last week. The US based medical devices giant, Medtronic’s growing…
Liked by Shakthi M Nagappan
-
We are proud to announce the 2024 India Research Grant Award winners. This grant is part of our esteemed collaboration with Garmin, a global leader…
We are proud to announce the 2024 India Research Grant Award winners. This grant is part of our esteemed collaboration with Garmin, a global leader…
Liked by Shakthi M Nagappan
-
Our vision to grow IT exports from around $30bn to $200bn through AI first multi-pronged initiatives: 1. Kickstarting with global AI summit in Sept…
Our vision to grow IT exports from around $30bn to $200bn through AI first multi-pronged initiatives: 1. Kickstarting with global AI summit in Sept…
Liked by Shakthi M Nagappan
Experience
-
Hyderabad Pharma City Ltd, Government of Telangana
-
-
-
-
-
-
-
-
-
-
-
-
Education
Publications
-
TRIPs and the innovation trends in the bio-phramaceutical industry
BioAsia, ISB
To many industry experts within and outside the Indian pharmaceutical industry, the recent changes to the Indian patent law is a watershed event this is likely to have long
term implications on the competitiveness of the industry. Yet even after seven years from the event little is known about how the changes influenced the industry. Many domestic
firms believe that the new patent law is likely to halt their aspirations to become a dominant generic player while many multinational firms…To many industry experts within and outside the Indian pharmaceutical industry, the recent changes to the Indian patent law is a watershed event this is likely to have long
term implications on the competitiveness of the industry. Yet even after seven years from the event little is known about how the changes influenced the industry. Many domestic
firms believe that the new patent law is likely to halt their aspirations to become a dominant generic player while many multinational firms believe that the new law will
open up their firms to new market opportunities well beyond those in the developed world. In this report we paint a broad brush on how the most recent changes to the
Indian patent law influenced firm strategies and the competitiveness of local players in the industry. Given the current sets of firm capabilities that Indian and foreign firms are armed with, we believe the new patent law is likely to result in both these categories of
firms reconfiguring their strategies. Also, how firms adapt to the new reality will determine their performance in this new era. We present our broad findings and our
conjecture on the long term implications of the new patent law on the Indian pharmaceutical industry.Other authors
Recommendations received
5 people have recommended Shakthi M
Join now to viewMore activity by Shakthi M
-
🌟 Thrilled to share my recent experience at the #GlobalTechnologyRetreat (GTR) hosted by the World Economic Forum at the Center for Fourth…
🌟 Thrilled to share my recent experience at the #GlobalTechnologyRetreat (GTR) hosted by the World Economic Forum at the Center for Fourth…
Liked by Shakthi M Nagappan
-
At BioAsia 2024, WEF C4IR Telangana signed a MoU with the National University of Singapore. Through this collaboration, we are excited to explore…
At BioAsia 2024, WEF C4IR Telangana signed a MoU with the National University of Singapore. Through this collaboration, we are excited to explore…
Liked by Shakthi M Nagappan
-
Miltenyi Biotec opens its first office in India and plans to invest in first of its kind Cell and Gene Therapy Center of Excellence Hyderabad…
Miltenyi Biotec opens its first office in India and plans to invest in first of its kind Cell and Gene Therapy Center of Excellence Hyderabad…
Liked by Shakthi M Nagappan
-
Hyderabad diaries (1): High-profile panel which incl senior execs/#legal eagles from #Novartis, #Bayer, #Sun Pharma, #MSF, IPA and Anand and Anand…
Hyderabad diaries (1): High-profile panel which incl senior execs/#legal eagles from #Novartis, #Bayer, #Sun Pharma, #MSF, IPA and Anand and Anand…
Liked by Shakthi M Nagappan
-
C4IR Telangana has identified major initiatives and “Skilling and Development” is one of them which aims to meet the industry demand with…
C4IR Telangana has identified major initiatives and “Skilling and Development” is one of them which aims to meet the industry demand with…
Liked by Shakthi M Nagappan
-
"The fusion of technology and artificial intelligence is undoubtedly the future of medical advancements. It's not just about innovating; it's about…
"The fusion of technology and artificial intelligence is undoubtedly the future of medical advancements. It's not just about innovating; it's about…
Liked by Shakthi M Nagappan
-
Cliniv Health Tech @Bio Asia 2024 #cliniv #bioasia
Cliniv Health Tech @Bio Asia 2024 #cliniv #bioasia
Liked by Shakthi M Nagappan
-
What a great 3 days at #BioAsia2024, full of networking, learning about recent trends in the life science community and making new friends. Thank you…
What a great 3 days at #BioAsia2024, full of networking, learning about recent trends in the life science community and making new friends. Thank you…
Liked by Shakthi M Nagappan
-
During my visit to this year’s @BioAsia2024, I had the pleasure of engaging with established and start-up businesses in the life sciences and…
During my visit to this year’s @BioAsia2024, I had the pleasure of engaging with established and start-up businesses in the life sciences and…
Liked by Shakthi M Nagappan
-
Amazing Experience at BioAsia 2024! 🚀 Our delegates, ALEX T KOSHY and Rupal Sheth, had the opportunity of participating in this esteemed event in…
Amazing Experience at BioAsia 2024! 🚀 Our delegates, ALEX T KOSHY and Rupal Sheth, had the opportunity of participating in this esteemed event in…
Liked by Shakthi M Nagappan
-
#bioasia2024 was a blast - Learning about new startups solving challenging problems, Forging collaborations with Companies, Deep discussions with…
#bioasia2024 was a blast - Learning about new startups solving challenging problems, Forging collaborations with Companies, Deep discussions with…
Liked by Shakthi M Nagappan
People also viewed
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore MoreOthers named Shakthi M Nagappan
1 other named Shakthi M Nagappan is on LinkedIn
See others named Shakthi M Nagappan